Covered recipient · General Payments record
KIMBERLY LYNN BAIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2023
$2,505.86
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $594.69 | 11 |
| Travel and Lodging | $519.68 | 5 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $1,033.26 | 12 |
| E.R. Squibb & Sons, L.L.C. | $27.17 | 1 |
| SEAGEN INC. | $21.89 | 1 |
| Abbott Laboratories | $16.48 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.48 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018122885 | CMS |
| E.R. Squibb & Sons, L.L.C. | $27.17 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016218071 | CMS |
| Medtronic, Inc. | $51.58 | 10/13/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1018959443 | CMS |
| Medtronic, Inc. | $189.00 | 10/13/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1018959453 | CMS |
| Medtronic, Inc. | $123.28 | 10/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018959460 | CMS |
| Medtronic, Inc. | $189.00 | 10/14/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1018959399 | CMS |
| Medtronic, Inc. | $51.76 | 10/14/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1018959407 | CMS |
| Medtronic, Inc. | $38.34 | 10/14/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1018959415 | CMS |
| Medtronic, Inc. | $68.21 | 10/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018959423 | CMS |
| Medtronic, Inc. | $93.29 | 10/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018959431 | CMS |
| Medtronic, Inc. | $70.77 | 10/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018959437 | CMS |
| Medtronic, Inc. | $70.34 | 10/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018959375 | CMS |
| Medtronic, Inc. | $58.81 | 10/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018959383 | CMS |
| Medtronic, Inc. | $28.88 | 10/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018959391 | CMS |
| Novartis Pharmaceuticals Corporation | $15.57 | 03/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 991616477 | CMS |
| Seagen Inc. | $21.89 | 10/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 995832625 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.